Posco Holdings Posted Net Loss in Fourth Quarter
By Kwanwoo Jun
Posco Holdings posted a net loss in the final quarter of 2023, ending its three-quarter streak of consecutive net profits.
The South Korean steelmaker said Wednesday that lower prices for carbon steel and lithium products weighed on its flagship steel business and new battery-material business.
The company's net loss for the quarter ended December was 321 billion won ($241.5 million), according to Posco officials. That compared with net profit of KRW550 billion in the previous quarter and a net loss of KRW737 billion a year earlier, when flood damage hobbled its main steel mill, according to figures from FactSet.
For the full year of 2023, revenue fell 9.0% to KRW77.127 trillion, operating profit dropped 27% to KRW3.531 trillion and net profit slumped 48% to KRW1.846 trillion.
Posco officials told a post-earnings conference call Wednesday that they don't expect any meaningful increase in steel sales in 2024.
The company aims to sell about 33 million tons of steel this year, a similar level to 2023, they said.
Write to Kwanwoo Jun at kwanwoo.jun@wsj.com
(END) Dow Jones Newswires
January 31, 2024 03:40 ET (08:40 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track